Drug patent expiration presents a significant opportunity for the launch of generic medications, which can dramatically alter market dynamics. When a branded drug's patent expires, it opens the door for generic manufacturers to produce and sell bioequivalent versions at a lower cost, leading to increased competition and reduced prices. This not only makes medications more accessible to patients but also creates substantial market opportunities for generic pharmaceutical companies.